JENOPTIK AG has refinanced its revolving syndicated loan and increased it from 230 to 400 million euros. The five-years term can be extended twice by one year each time (5 + 1 + 1), so the volume can be increased […]
Author: Firma JENOPTIK-KONZERN
With its new Agenda 2025, “MORE VALUE”, Jenoptik focuses on sustainable profitable growth in core photonics markets
Posted on Posted in General
Accelerated transformation into a pure photonics player In future, stronger focus on three core markets: semiconductors/ electronics, life science/medical technology, and smart mobility Revenue set to rise to around 1.2 billion euros, with an EBITDA margin of approximately 20 percent, […]
Jenoptik: Successful closing of the acquisition of BG Medical and SwissOptic
Posted on Posted in General
With the closing on November 30, 2021, JENOPTIK AG (FSE: JEN / ISIN: DE000A2NB601 successfully concluded the acquisition of the following companies as announced in October: BG Medical Applications GmbH ("BG Medical"), a supplier of high-precision, custom optical components for […]
JENOPTIK AG signs agreement to sell VINCORION
Posted on Posted in General
JENOPTIK AG has signed an agreement to sell the VINCORION division. It will be acquired by a fund managed by STAR Capital Partnership LLP (“STAR”). STAR is a leading private equity firm investing in medium-sized companies across Europe. VINCORION develops, […]
Jenoptik with continued growth
Posted on Posted in General
Q3 revenue up 24.9 percent on prior year – nine-month revenue up 20.6 percent to 609.2 million euros Substantially improved profitability – EBITDA margin at 21.6 percent in reporting quarter and at 19.9 percent after nine months Ongoing strong demand […]
For human rights and environmental protection: Jenoptik joins UN Global Compact
Posted on Posted in General
Clear commitment to sustainability by joining the world’s largest and most important initiative for responsible corporate management. By signing up to become a member of the “United Nations Global Compact”, the global United Nations network for corporate responsibility, the Jenoptik […]
Jenoptik strengthens global photonics business with the acquisition of Berliner Glas Medical and SwissOptic
Posted on Posted in General
Accelerated growth and stronger focus on photonics Expansion of global presence in attractive markets, predominantly the semiconductor equipment and medical technology industries Broadening of product and technology portfolio JENOPTIK AG (FSE: JEN / ISIN: DE000A2NB601) is set to acquire […]
Jenoptik will more than double on-site production capacity for its micro-optics business in Dresden
Posted on Posted in General
The Jenoptik Group intends to build a state-of-the-art production building with office complex in Dresden. In total, the photonics group is planning to invest around 70 million euros in a cleanroom facility for micro-optics and sensors for semiconductor equipment. Jenoptik […]
Jenoptik: Record figures achieved in 2nd quarter; strong performance expected to continue in 2nd half of 2021
Posted on Posted in General
Revenue up 29.6 percent in 2nd quarter compared with prior year – half-year revenue increased by 18.3 percent to 389.3 million euros EBITDA margin of 25.2 percent in 2nd quarter, and 18.9 percent in 1st half of 2021 High demand […]
Jenoptik achieves record figures in the 2nd quarter 2021 and raises guidance for fiscal year 2021
Posted on Posted in General
The Jenoptik Group achieved record figures in order intake, revenue and EBITDA in the 2nd quarter 2021. From April to June order intake almost doubled compared with the prior-year period, revenue grew by almost 30 percent and EBITDA by approx. […]